Modeling the Interaction of Interferon α-1b to Bovine Serum Albumin as a Drug Delivery System

被引:7
作者
Luo, Qi [1 ,2 ]
Wang, Yihui [3 ]
Yang, Hongge [3 ]
Liu, Chang [3 ]
Ding, Yuan [3 ]
Xu, Haifeng [3 ]
Wang, Qi [1 ,2 ]
Liu, Yingchun [1 ,2 ]
Xie, Ying [3 ]
机构
[1] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310027, Zhejiang, Peoples R China
[2] Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China
[3] Peking Univ, Sch Pharmaceut Sci, Dept Pharmaceut, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
MOLECULAR DOCKING; PROTEIN DRUGS; IN-VITRO; NANOPARTICLES; RELEASE; PEPTIDE; BRIDGES;
D O I
10.1021/jp5041713
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Protein-based nanoparticles represent a promising approach to carry polypeptide and protein drugs. Using both theory and experimentation, an interferon alpha-1b (IFN) delivery system carried by bovine serum albumin (BSA) nanoparticles was designed. Theoretical results indicate the most probable binding site and interaction mechanism for IFN on BSA. IFN has a higher binding affinity with BSA compared with small chemical drugs. The drug loading is about 8 mg/g, significantly higher than those reported in other literature. The release profiles differ between the nanoparticles prepared by the incorporation method and the adsorption method. The adsorption of IFN on BSA nanoparticles is monolayer adsorption. The fact that IFN was carried successfully by BSA nanoparticles establishes a solid basis for expanding the drug loading field of BSA nanoparticles to proteins and polypeptides.
引用
收藏
页码:8566 / 8574
页数:9
相关论文
共 42 条
  • [1] Probing the Binding Sites of Antibiotic Drugs Doxorubicin and N-(trifluoroacetyl) Doxorubicin with Human and Bovine Serum Albumins
    Agudelo, Daniel
    Bourassa, Philippe
    Bruneau, Julie
    Berube, Gervais
    Asselin, Eric
    Tajmir-Riahi, Heidar-Ali
    [J]. PLOS ONE, 2012, 7 (08):
  • [2] Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion
    Albers, Jessica
    Alles, Rainer
    Matthee, Karin
    Knop, Klaus
    Nahrup, Julia Schulze
    Kleinebudde, Peter
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (02) : 387 - 394
  • [3] Anatomy of hot spots in protein interfaces
    Bogan, AA
    Thorn, KS
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1998, 280 (01) : 1 - 9
  • [4] STRUCTURE OF HUMAN SERUM-ALBUMIN
    CARTER, DC
    HE, XM
    [J]. SCIENCE, 1990, 249 (4966) : 302 - 303
  • [5] Long-acting growth hormones produced by conjugation with polyethylene glycol
    Clark, R
    Olson, K
    Fuh, G
    Marian, M
    Mortensen, D
    Teshima, F
    Chang, S
    Chu, H
    Mukku, V
    CanovaDavis, E
    Somer, T
    Cronin, M
    Winkler, M
    Wells, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (36) : 21969 - 21977
  • [6] PARTICLE MESH EWALD - AN N.LOG(N) METHOD FOR EWALD SUMS IN LARGE SYSTEMS
    DARDEN, T
    YORK, D
    PEDERSEN, L
    [J]. JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (12) : 10089 - 10092
  • [7] A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations
    Duan, Y
    Wu, C
    Chowdhury, S
    Lee, MC
    Xiong, GM
    Zhang, W
    Yang, R
    Cieplak, P
    Luo, R
    Lee, T
    Caldwell, J
    Wang, JM
    Kollman, P
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2003, 24 (16) : 1999 - 2012
  • [8] Protein-based nanocarriers as promising drug and gene delivery systems
    Elzoghby, Ahmed O.
    Samy, Wael M.
    Elgindy, Nazik A.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2012, 161 (01) : 38 - 49
  • [9] Albumin-based nanoparticles as potential controlled release drug delivery systems
    Elzoghby, Ahmed O.
    Samy, Wael M.
    Elgindy, Nazik A.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2012, 157 (02) : 168 - 182
  • [10] Are all Type I human interferons equivalent?
    Foster, GR
    Finter, NB
    [J]. JOURNAL OF VIRAL HEPATITIS, 1998, 5 (03) : 143 - 152